No earnings within 2 weeks of this transaction.
| Insider | Frazier Life Sciences XI, L.P. |
|---|---|
| Title | 10% Owner |
| Transaction Date | Aug 6, 2026 |
| Transaction Code | C Conversion |
| Acquired/Disposed | Disposed |
| Security | Series A-1 Preferred Stock |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Aug 6, 2026 |
| Shares Purchased | 16,250,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Derivative | Derivative |
| Accession Number | 0001231919-26-000838 |
| Document | View SEC Filing |